SCHEMBL22063333

SCHEMBL22063333

CC(C)c1ccc(-c2cc3c4c(c2)n2c5ccccc5nc2n4c2nc4ccccc4n32)c(-c2ccccc2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 1/20 0.37
KDM4E B2RXH2 7/20 0.36
ALDH1A1 P00352 5/20 0.36
HPGD P15428 5/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
GAA P10253 3/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAPK1 P28482 1/20 0.35
TP53 P04637 4/20 0.34
MAPT P10636 4/20 0.34
HSD17B10 Q99714 4/20 0.34
LMNA P02545 4/20 0.34
POLB P06746 3/20 0.34
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TSHR P16473 1/20 0.34
TYMS P04818 1/20 0.34
METAP2 P50579 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22063340 1.00 CASR (0.37) CASRKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22062557 0.89 METAP2 (0.34) CASRKDM4EALDH1A1HSD17B10LMNA
SCHEMBL22088872 0.87 KDM4E (0.33) CASRKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22087787 0.87 KDM4E (0.33) CASRKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22062535 0.85 ALDH1A1 (0.44) KDM4EALDH1A1HPGDSMN1; SMN2GAA
SCHEMBL22063193 0.84 PSMB5 (0.42) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL22063044 0.84 PSMB5 (0.42) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL22063052 0.84 ALDH1A1 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2GAA
SCHEMBL22063059 0.84 ALDH1A1 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2GAA
SCHEMBL22063201 0.83 KDM4E (0.39) CASRKDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EMC2, NFE2L2, AOC2 CASR 3390/4885KDM4E 1152/4885ALDH1A1 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.